Transcriptional effects of (177)Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

BACKGROUND: (177)Lu-octreotate is used for therapy of somatostatin receptor expressing neuroendocrine tumors with promising results, although complete tumor remission is rarely seen. Previous studies on nude mice bearing the human small intestine neuroendocrine tumor, GOT1, have shown that a priming...

Descripción completa

Detalles Bibliográficos
Autores principales: Spetz, Johan, Langen, Britta, Rudqvist, Nils-Petter, Parris, Toshima Z., Shubbar, Emman, Dalmo, Johanna, Wängberg, Bo, Nilsson, Ola, Helou, Khalil, Forssell-Aronsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426909/
https://www.ncbi.nlm.nih.gov/pubmed/30895393
http://dx.doi.org/10.1186/s13550-019-0500-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426909/
https://www.ncbi.nlm.nih.gov/pubmed/30895393
http://dx.doi.org/10.1186/s13550-019-0500-2

Ejemplares similares